Publications by authors named "Parkavi Kalaiselvan"

Claim this Profile
C
COVID-19 Infections and Inflammatory Markers in Patients Hospitalized During the First Year of the Pandemic.
Parkavi Kalaiselvan, Pitchaporn Yingchoncharoen, Jerapas Thongpiya, Arunee Motes, Kenneth Nugent

J Prim Care Community Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells.
Yaongamphi Vashum, Amuthavalli Kottaiswamy, Giridharan Bupesh, Riya P Singh, Parkavi Kalaiselvan

Curr Mol Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Citrus Flavanone Hesperetin Induces Apoptosis in CTCL Cells STAT3/Notch1/NFκB-Mediated Signaling Axis.
Amuthavalli Kottaiswamy, Atish Kizhakeyil, Abirami M Padmanaban, Fathima B Mirza, Venkatesh R Vijay, Parkavi Kalaiselvan

Anticancer Agents Med Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Yaongamphi Vashum, Riya Premsingh, Amuthavalli Kottaiswamy, Mathangi Soma, Abirami Padmanaban, Parkavi Kalaiselvan

Mol Biol Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: Therapeutic prospect of epigallocatechin-3-gallate.
Thangarajeswari Mohan, Kishore Kumar S Narasimhan, Divya Bhavani Ravi, Prema Velusamy, Navvi Chandrasekar, Parkavi Kalaiselvan

Free Radic Biol Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis